Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126853801 | 12685380 | 1 | I | 20150709 | 20150723 | 20160825 | 20160825 | PER | US-NOVOPROD-458571 | NOVO NORDISK | 48.00 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126853801 | 12685380 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | UNK | DS6M917 | 22341 | SOLUTION FOR INJECTION | ||||||||
126853801 | 12685380 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, QD | DS6M917 | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126853801 | 12685380 | 1 | Weight decreased |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126853801 | 12685380 | Abdominal discomfort | |
126853801 | 12685380 | Decreased appetite | |
126853801 | 12685380 | Dysgeusia | |
126853801 | 12685380 | Eructation | |
126853801 | 12685380 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126853801 | 12685380 | 1 | 20150709 | 20150715 | 0 | |
126853801 | 12685380 | 2 | 20150716 | 0 |